Publisher: Elsevier

Related content
Volume 5, Number 9, 1 September 2000

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

A new target for HIV-1 entry inhibition?
pp. 380-381(2)
Author: Lawrence, R.N.

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Virtual drug resistance testing in HIV
pp. 384-385(2)
Author: Dorrell, S.

Favourites:Add to Favourites

News in brief
pp. 385-387(3)
Authors: Lawrence, R.N.; Ramster, B.

Favourites:Add to Favourites

Making drug discovery a SN(i)P
pp. 388-396(9)
Authors: Campbell, D.A.; Valdes, A.; Spurr, N.

Favourites:Add to Favourites

Identification and in vivo efficacy of small-molecule antagonists of integrin αv3 (the vitronectin receptor)
pp. 397-408(12)
Authors: Miller, W.H.; Keenan, R.M.; Willette, R.N.; Lark, M.W.

Favourites:Add to Favourites

ADME/PK as part of a rational approach to drug discovery
pp. 409-414(6)
Authors: Eddershaw, P.J.; Beresford, A.P.; Bayliss, M.K.

Favourites:Add to Favourites

Serial analysis of gene expression: from gene discovery to target identification
pp. 415-425(11)
Authors: Madden, S.L.; Wang, C.J.; Landes, G.

Favourites:Add to Favourites

Monitor: molecules and profiles
pp. 427-429(3)
Author: Lloyd, A.W.

Favourites:Add to Favourites
Favourites:Add to Favourites

Contribution of NO/ONOO- pathway to the deleterious effect of traumatic brain injury in mice
pp. 432-433(2)
Authors: Mesenge, C.; Verrecchia, C.; Charriaut-Marlangue, C.; Margaill, I.; Boulu, R.G.; Plotkine, M.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more